fashion -WSS

fashion

author：hotspot 2025-10-01 02:15:22 - browse：91374

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： H.R. 3 is the wrong path to lower drug costs

WSS

In key trial, Verve's treatment lowers cholesterol levels in patients

CRISPR pioneers react to Casgevy, first gene

CRISPR pioneers react to Casgevy, first gene

Does good food count as health care? Study aims to find out

Surge of respiratory disease in China has likely explanation

Late stage cancers on the rise after pandemic delayed screenings

entertainment

fashion

hotspot

Psychedelics group wrestles with new pharma identity

H.R. 3 is the wrong path to lower drug costs

Duchenne breakthrough therapy leaves behind pioneering families

Pharma showers House GOP doctor with campaign cash

State Dept. review finds Biden bears some blame for Afghanistan failures

Heart disease in astronauts blamed on cosmic radiation

United colonoscopy coverage change 'may cost lives,' doctors say

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Wegovy, Zepbound and weight loss drugs that preserve muscle

hotspot

When waiting feels immoral: Empathy in the emergency department

Medicare slashes safety net hospital payments by nearly $1 billion

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Poor hospice wound care hurts patients and families

Morphosys mixed study results for blood cancer drug

2 officers injured in shooting in Orlando, police say

leisure time

hotspot

focus

leisure time